Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 5
2011 3
2012 1
2013 2
2014 1
2015 2
2016 1
2017 6
2018 1
2019 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study.
Yoo DH, Hrycaj P, Miranda P, Ramiterre E, Piotrowski M, Shevchuk S, Kovalenko V, Prodanovic N, Abello-Banfi M, Gutierrez-Ureña S, Morales-Olazabal L, Tee M, Jimenez R, Zamani O, Lee SJ, Kim H, Park W, Müller-Ladner U. Yoo DH, et al. Among authors: prodanovic n. Ann Rheum Dis. 2013 Oct;72(10):1613-20. doi: 10.1136/annrheumdis-2012-203090. Epub 2013 May 16. Ann Rheum Dis. 2013. PMID: 23687260 Free PMC article. Clinical Trial.
Open scapulothoracic dissociation.
Stepanovic ZL, Milisavljevic SS, Prodanovic NS, Stahel PF; With expert commentary by. Stepanovic ZL, et al. Among authors: prodanovic ns. J Trauma Acute Care Surg. 2015 Oct;79(4):698-700. doi: 10.1097/TA.0000000000000798. J Trauma Acute Care Surg. 2015. PMID: 26402548 No abstract available.
Androgen status in non-diabetic elderly men with heart failure.
Loncar G, Bozic B, Neskovic AN, Cvetinovic N, Lainscak M, Prodanovic N, Dungen HD, von Haehling S, Radojicic Z, Trippel T, Putnikovic B, Markovic-Nikolic N, Popovic V. Loncar G, et al. Among authors: prodanovic n. Aging Male. 2017 Dec;20(4):215-224. doi: 10.1080/13685538.2017.1350155. Epub 2017 Jul 11. Aging Male. 2017. PMID: 28696825
Interleukin-6 as possible early marker of stress response after femoral fracture.
Pesic G, Jeremic J, Nikolic T, Zivkovic V, Srejovic I, Vranic A, Bradic J, Ristic B, Matic A, Prodanovic N, Jakovljevic V. Pesic G, et al. Among authors: prodanovic n. Mol Cell Biochem. 2017 Jun;430(1-2):191-199. doi: 10.1007/s11010-017-2967-3. Epub 2017 Feb 16. Mol Cell Biochem. 2017. PMID: 28210899 Clinical Trial.
Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition study.
Smolen JS, Choe JY, Prodanovic N, Niebrzydowski J, Staykov I, Dokoupilova E, Baranauskaite A, Yatsyshyn R, Mekic M, Porawska W, Ciferska H, Jedrychowicz-Rosiak K, Zielinska A, Lee Y, Rho YH. Smolen JS, et al. Among authors: prodanovic n. Ann Rheum Dis. 2018 Feb;77(2):234-240. doi: 10.1136/annrheumdis-2017-211741. Epub 2017 Oct 17. Ann Rheum Dis. 2018. PMID: 29042358 Free PMC article. Clinical Trial.
The Republic of Srpska Iodine Deficiency Survey 2006.
Lolic A, Prodanovic N. Lolic A, et al. Among authors: prodanovic n. Hormones (Athens). 2008 Apr-Jun;7(2):163-9. doi: 10.1007/BF03401508. Hormones (Athens). 2008. PMID: 18477554 Free article.
Comparing biosimilar SB2 with reference infliximab after 54 weeks of a double-blind trial: clinical, structural and safety results.
Smolen JS, Choe JY, Prodanovic N, Niebrzydowski J, Staykov I, Dokoupilova E, Baranauskaite A, Yatsyshyn R, Mekic M, Porawska W, Ciferska H, Jedrychowicz-Rosiak K, Zielinska A, Choi J, Rho YH. Smolen JS, et al. Among authors: prodanovic n. Rheumatology (Oxford). 2017 Oct 1;56(10):1771-1779. doi: 10.1093/rheumatology/kex254. Rheumatology (Oxford). 2017. PMID: 28957563 Free PMC article. Clinical Trial.
19 results